Stay updated with breaking news from Johnm Evans. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Sectoral Asset Management Inc. lessened its stake in shares of Beam Therapeutics Inc. (NASDAQ:BEAM – Get Rating) by 3.3% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 63,500 shares of the company’s stock after selling 2,200 shares during the quarter. Sectoral Asset Management […]
Beam Therapeutics (NASDAQ:BEAM – Get Rating) had its price target cut by Royal Bank of Canada from $50.00 to $42.00 in a report issued on Thursday, The Fly reports. BEAM has been the subject of a number of other research reports. William Blair reiterated an outperform rating on shares of Beam Therapeutics in a research […]
Beam Therapeutics (NASDAQ:BEAM – Get Rating) had its price objective cut by stock analysts at Royal Bank of Canada from $50.00 to $42.00 in a note issued to investors on Thursday, The Fly reports. Royal Bank of Canada’s target price points to a potential upside of 18.74% from the stock’s previous close. A number of […]
Shares of Beam Therapeutics Inc. (NASDAQ:BEAM – Get Rating) have been assigned an average recommendation of “Moderate Buy” from the eleven analysts that are covering the stock, Marketbeat reports. Three analysts have rated the stock with a hold recommendation and seven have assigned a buy recommendation to the company. The average 1-year target price among […]
Los Angeles Capital Management LLC raised its holdings in shares of Beam Therapeutics Inc. (NASDAQ:BEAM – Get Rating) by 34.1% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 16,496 shares of the company’s stock after purchasing an additional 4,199 shares […]